checkAd

     109  0 Kommentare Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board - Seite 3

    Sonoma Pharmaceuticals™ is a trademark of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.

    Media and Investor Contact:
    Sonoma Pharmaceuticals, Inc.
    ir@sonomapharma.com

    Lesen Sie auch

    SOURCE: Sonoma Pharmaceuticals, Inc.



    View source version on accesswire.com:
    https://www.accesswire.com/771921/Sonoma-Pharmaceuticals-Announces-App ...


    The Sonoma Pharmaceuticals Stock at the time of publication of the news with a raise of +0,44 % to 0,914EUR on Lang & Schwarz stock exchange (03. August 2023, 13:29 Uhr).

    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Accesswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board - Seite 3 BOULDER, CO / ACCESSWIRE / August 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of …